PERTOSA, ANNA MARIA
 Distribuzione geografica
Continente #
NA - Nord America 916
EU - Europa 622
AS - Asia 234
AF - Africa 37
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 1.812
Nazione #
US - Stati Uniti d'America 915
GB - Regno Unito 183
SE - Svezia 103
VN - Vietnam 96
UA - Ucraina 70
DE - Germania 67
CN - Cina 59
IT - Italia 56
CH - Svizzera 32
FR - Francia 31
IN - India 30
SG - Singapore 30
IE - Irlanda 26
RU - Federazione Russa 21
TG - Togo 19
ZA - Sudafrica 13
BG - Bulgaria 11
EE - Estonia 9
JO - Giordania 6
JP - Giappone 6
GR - Grecia 4
IR - Iran 4
SC - Seychelles 4
CZ - Repubblica Ceca 3
BE - Belgio 2
UZ - Uzbekistan 2
AU - Australia 1
CA - Canada 1
CI - Costa d'Avorio 1
EU - Europa 1
NL - Olanda 1
NZ - Nuova Zelanda 1
PL - Polonia 1
RO - Romania 1
SI - Slovenia 1
TR - Turchia 1
Totale 1.812
Città #
Southend 157
Chandler 125
Fairfield 117
Seattle 65
Woodbridge 65
Ashburn 62
Cambridge 61
Jacksonville 49
Dong Ket 47
Houston 45
Wilmington 43
Ann Arbor 38
Bern 31
Princeton 31
Singapore 27
Dublin 26
Lomé 19
Nanjing 16
Padova 15
Westminster 15
Berlin 11
Sofia 11
Florence 9
Boardman 7
Mülheim 7
Verona 7
Amman 6
Mountain View 6
Norwalk 6
Saint Petersburg 6
San Diego 6
Turin 6
Beijing 5
Dearborn 5
Hebei 5
Milan 5
Santa Clara 5
Shenyang 5
Tokyo 5
Jinan 4
Mahé 4
Nanchang 4
Redwood City 4
Kunming 3
Los Angeles 3
Medford 3
Olomouc 3
Ardabil 2
Bremen 2
Brussels 2
Bühl 2
Changsha 2
Des Moines 2
Hangzhou 2
London 2
New York 2
Ningbo 2
Paris 2
Tianjin 2
Abidjan 1
Augusta 1
Costa Mesa 1
Den Haag 1
Frankfurt am Main 1
Fuzhou 1
Golders Green 1
Guangzhou 1
Haikou 1
Hefei 1
Kilburn 1
Lanzhou 1
Las Vegas 1
Lausanne 1
Leawood 1
Ljubljana 1
North Bergen 1
Olalla 1
Olinda 1
Poole 1
Taiyuan 1
Tallinn 1
Ulan-ude 1
Vigarano Mainarda 1
Washington 1
Wellington 1
Winnipeg 1
Zanjan 1
Zhengzhou 1
Totale 1.258
Nome #
A novel sodium overload test predicting ascites decompensation in rats with CCl4-induced cirrhosis. 177
A novel sodium overload test predicting ascites decompensation in rats with CCL4-induced cirrhosis. 141
Antagonism of the cannabinoid CB-1 receptor protects rat liver against ischemia-reperfusion injury complicated by endotoxemia. 137
The reduced tolerance of rat fatty liver to ischemia-reperfusion is associated to mitochondrial oxidative injury. 135
Effects of granulocyte colony stimulating-factor in a rat model of acute liver injury. 133
The nutritional status modulates preservation-reperfusion injury in rat fatty liver. 130
Successful treatment of CCl4-induced acute liver failure with portal vein arterialization in the rat. 126
Oxidative injury in rat fatty liver exposed to ischemia-reperfusion is modulated by nutritional status. 125
Portal vein arterialization for the treatment of post resection acute liver failure in the rat. 123
Cannabinoid type 1 receptor antagonism delays ascites formation in rats with cirrhosis cannabinoid type 1 receptor antagonism delays ascites formation in rats with cirrhosis. 116
Portal vein arterialization increases liver regeneration in acute liver failure induced by extended hepatectomy or toxin administration in the rat 107
Protective effect of portal vein arterialization in acute liver failure induced by hepatectomy in normal and Fatty liver rat. 102
Variable activation of phosphoinositide 3-kinase influences the response of liver grafts to ischemic preconditioning. 100
Successful treatment of CCL4-induced acute liver failure with portal vein arterialization in the rat. 93
Effect of the cannabinoid CB1 receptor antagonist SR141716 in a rat model of liver inflammation 89
Totale 1.834
Categoria #
all - tutte 4.200
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.200


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020436 0 7 8 33 52 57 69 70 63 34 22 21
2020/2021285 59 15 3 19 8 16 3 18 20 22 15 87
2021/2022349 45 10 26 36 24 13 6 18 11 28 86 46
2022/2023391 39 70 23 48 22 28 9 13 68 4 30 37
2023/202480 4 16 3 9 12 17 2 3 4 5 3 2
2024/202547 12 35 0 0 0 0 0 0 0 0 0 0
Totale 1.834